NovaBay Pharmaceuticals, Inc. (NBY) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference  
1/31/2013 9:41:16 AM

EMERYVILLE, Calif., Jan. 31, 2013 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that Dr. Ron Najafi, Chief Executive Officer, will present at the 15th Annual BIO CEO & Investor Conference, held February 11-12, 2013, in New York, NY.